BRPI0416292A - composições estabilizadas compreendendo probióticos - Google Patents

composições estabilizadas compreendendo probióticos

Info

Publication number
BRPI0416292A
BRPI0416292A BRPI0416292-7A BRPI0416292A BRPI0416292A BR PI0416292 A BRPI0416292 A BR PI0416292A BR PI0416292 A BRPI0416292 A BR PI0416292A BR PI0416292 A BRPI0416292 A BR PI0416292A
Authority
BR
Brazil
Prior art keywords
compositions
probiotics
bacterial
stabilized
stabilized compositions
Prior art date
Application number
BRPI0416292-7A
Other languages
English (en)
Inventor
Graham John Myatt
Duane Larry Charbonneau
Kevin Ian Trevor Wright
Martin Hallissey
Original Assignee
Procter & Gamble
Alimentary Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34552077&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0416292(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble, Alimentary Health Ltd filed Critical Procter & Gamble
Publication of BRPI0416292A publication Critical patent/BRPI0416292A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"COMPOSIçõES ESTABILIZADAS COMPREENDENDO PROBIóTICOS". A presente invenção refere-se a apresentadas composições bacterianas secas estabilizadas, compreendendo mais de 10 % em concentrado bacteriano seco tendo uma concentração de bactérias de pelo menos 1 x 10¬ 8¬ cfu/g. As composições têm melhor estabilidade. A invenção refere-se também a composições bacterianas embaladas, composições de dose unitária e métodos para a produção das composições da presente invenção.
BRPI0416292-7A 2003-11-07 2004-11-08 composições estabilizadas compreendendo probióticos BRPI0416292A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/704,253 US20050100559A1 (en) 2003-11-07 2003-11-07 Stabilized compositions comprising a probiotic
PCT/US2004/037428 WO2005047489A1 (en) 2003-11-07 2004-11-08 Stabilized compositions comprising probiotics

Publications (1)

Publication Number Publication Date
BRPI0416292A true BRPI0416292A (pt) 2007-01-23

Family

ID=34552077

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416292-7A BRPI0416292A (pt) 2003-11-07 2004-11-08 composições estabilizadas compreendendo probióticos

Country Status (11)

Country Link
US (2) US20050100559A1 (pt)
EP (1) EP1680501B1 (pt)
JP (1) JP2007508035A (pt)
CN (1) CN1875094A (pt)
AU (1) AU2004290037B2 (pt)
BR (1) BRPI0416292A (pt)
CA (1) CA2545148A1 (pt)
IN (1) IN2006DE02381A (pt)
MX (1) MX294225B (pt)
RU (1) RU2359027C2 (pt)
WO (1) WO2005047489A1 (pt)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US8192733B2 (en) 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) * 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
US8246946B2 (en) * 2005-09-27 2012-08-21 Cobb & Associates Treatment of bipolar disorder utilizing anti-fungal compositions
US20070077238A1 (en) * 2005-10-04 2007-04-05 Teo Alex Y Production of organic and inorganic selenium compounds by lactic acid bacteria
KR101393718B1 (ko) 2005-10-11 2014-05-13 프로바이오티컬 에스.피.에이. 비알레르기성 프로바이오틱 박테리아 배양물의 제조 방법 및 관련 용도
SI1962873T1 (sl) * 2005-12-14 2013-10-30 Oxthera Intellectual Property Ab Farmacevtski sestavki, ki vsebujejo bakterijo za zmanjšanje oksalata
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
WO2007079147A2 (en) 2005-12-28 2007-07-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP1978979B1 (en) * 2006-01-04 2014-08-13 Wikström, Maude Probiotic oral health promoting product
CN101172118A (zh) * 2006-07-26 2008-05-07 美国医迈科技有限公司 作为抗传染病替代药物的益生微生物
US20080095752A1 (en) * 2006-10-20 2008-04-24 Win-Chin Chiang Method for extending the shelf-life of powdered nutritional formulations which contain viable probiotics
JP5285617B2 (ja) 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
RU2009133376A (ru) * 2007-03-27 2011-05-10 Дзе Проктер Энд Гэмбл Компани (US) Способы и наборы для введения пробиотиков
NZ555022A (en) * 2007-11-07 2010-09-30 Encoate Holdings Ltd Stabilisation of dried biological material with oil and biopolymer
RU2010132283A (ru) * 2008-02-06 2012-03-20 Дзе Проктер Энд Гэмбл Компани (US) Композиции, способы и наборы для повышения иммунного ответа на респираторное заболевание
JP5334033B2 (ja) * 2008-03-25 2013-11-06 学校法人順天堂 哺乳類精子の保存方法
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2318511B1 (en) * 2008-08-28 2017-08-02 Chr. Hansen A/S Bacterial composition
EP3266448B1 (en) 2009-03-27 2022-02-16 Intervet International B.V. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
US20100260695A1 (en) * 2009-04-09 2010-10-14 Mary Kay Inc. Combination of plant extracts to improve skin tone
EP2243487A1 (en) * 2009-04-23 2010-10-27 Actogenix N.V. Enteric coated formulation
US20110104327A1 (en) * 2009-04-23 2011-05-05 Bacterfield International S.A. Probiotic pet food
ES2425385T3 (es) 2009-04-30 2013-10-15 Actogenix N.V. Crioprotectores para la liofilización de las bacterias de ácido láctico
SG176253A1 (en) 2009-05-26 2011-12-29 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
CN102595935A (zh) * 2009-07-27 2012-07-18 雀巢产品技术援助有限公司 包含纤维和益生菌的营养组合物
US9173423B2 (en) * 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
EP2289527B1 (en) * 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
NZ601017A (en) 2010-01-28 2014-07-25 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
EP4663746A3 (en) 2010-02-01 2026-04-15 Ferring Microbiome Inc. Bacteriotherapy for clostridium difficile colitis
EP2228067B1 (de) * 2010-02-22 2013-12-11 LR Health & Beauty Systems GmbH Probiotische Zusammensetzung und deren Verwendung
WO2011114182A1 (en) * 2010-03-17 2011-09-22 Compagnie Gervais Danone Dried fermented dairy product containing a high density of living bifidobacteria
PL2598165T3 (pl) * 2010-07-26 2018-02-28 Qu Biologics Inc. Immunogenne kompozycje przeciwzapalne
CL2011001984A1 (es) 2010-08-13 2012-06-29 Advanced Bionutrition Corp Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora.
DK2654417T3 (en) * 2010-12-23 2018-10-29 Dupont Nutrition Biosci Aps COLD PROTECTIVE COMPOSITIONS AND APPLICATIONS THEREOF
WO2013001089A1 (en) 2011-06-30 2013-01-03 Chr. Hansen A/S Novel compositions
DK2744888T3 (en) * 2011-08-18 2018-03-12 Chr Hansen As Process for purifying bacterial cells
IN2014DN07752A (pt) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
JP6219938B2 (ja) 2012-06-13 2017-10-25 クレクストラル プロバイオティックまたは他の微生物を含有する多孔性粉末製品の製造方法
JP6230796B2 (ja) * 2013-03-08 2017-11-15 日清食品ホールディングス株式会社 凍結乾燥菌試料およびその製造方法
US9919262B2 (en) * 2013-11-07 2018-03-20 Shell Oil Company Process for capturing sulfur dioxide from a gas stream
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
WO2016109853A2 (en) 2015-01-02 2016-07-07 Melaleuca, Inc. Dietary supplement compositions
TWI788111B (zh) 2015-01-02 2022-12-21 美商梅拉洛伊卡公司 多元補充品組成物
TWI829098B (zh) 2015-01-02 2024-01-11 美商梅拉洛伊卡公司 細菌組成物
CN120436205A (zh) 2015-02-13 2025-08-08 马斯公司 包装宠物食物产品
WO2016133909A1 (en) 2015-02-16 2016-08-25 Mars, Incorporated Interlocking kibble
JP2016193894A (ja) * 2015-04-01 2016-11-17 京都薬品工業株式会社 生菌含有製剤
RU2592988C1 (ru) * 2015-04-10 2016-07-27 Александр Владимирович Синица Синбиотическая композиция для коррекции дисбиотических нарушений микробиоценоза желудочно-кишечного тракта
EP3288394A4 (en) 2015-04-28 2019-01-23 Mars, Incorporated METHOD FOR PRODUCING A STERILIZED PET WET FOOD PRODUCT
MX380541B (es) * 2015-06-30 2025-03-12 Soc Des Produits Nestle S A Star Composición adecuada para proteger microorganismos.
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
EP3328215B1 (en) 2015-07-29 2021-07-07 Advanced BioNutrition Corp. Stable dry probiotic compositions for special dietary uses
RU2018105356A (ru) 2015-08-27 2019-09-30 Дзе Проктер Энд Гэмбл Компани Бифидобактерия bifidobacterium longum
US12239706B2 (en) 2015-11-30 2025-03-04 Seed Health, Inc. Method and system for protecting monarch butterflies from pesticides
US12318475B2 (en) 2016-03-14 2025-06-03 The University Of Chicago Injectable pastes based on oppositely charged polymer/calcium phosphate nanoparticles
WO2018078065A1 (en) 2016-10-27 2018-05-03 Shell Internationale Research Maatschappij B.V. Process for removing sulfur dioxide from a gas stream
US10807038B2 (en) 2017-03-08 2020-10-20 Shell Oil Company Process for removing S02 from gas with S02 content that is temporarily very high
US12042519B2 (en) * 2017-07-14 2024-07-23 The University Of Chicago Freeze-dried formulations including nanoparticles and methods of freeze-drying
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
AU2018330322A1 (en) 2017-09-08 2020-03-19 Evelo Biosciences, Inc. Bacterial extracellular vesicles
CN108113003A (zh) * 2017-12-15 2018-06-05 浙江康诺邦健康产品有限公司 一种适合婴幼儿的益生菌软胶囊及其制备方法
US20200345055A1 (en) * 2018-01-17 2020-11-05 Evolve Biosystems, Inc. Activation of conditionally-expressed oligosaccharide pathways during fermentation of probiotic strains
DK3745870T3 (da) * 2018-01-29 2023-02-20 Prec Group Limited Et kombinationsprodukt til profylakse og behandling af irritabel tarmsyndrom
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
WO2020055547A2 (en) 2018-08-18 2020-03-19 Seed Health, Inc. Methods and compositions for honey bee health
WO2020104612A1 (en) * 2018-11-21 2020-05-28 Evonik Operations Gmbh Dried biological compositions and methods thereof
EP3890505A4 (en) * 2018-12-05 2022-11-02 Seres Therapeutics, Inc. COMPOSITIONS FOR STABILIZING BACTERIA AND THEIR USES
EA202192291A1 (ru) * 2019-04-15 2022-02-11 Институт Д'Инвестигасьонс Биомедикас Аугуст Пи И Суньер (Идибапс) Композиция, содержащая стабильную в течение длительного времени живую фекальную микробиоту
EP4117697A1 (en) * 2020-03-13 2023-01-18 PrecisionBiotics Group Limited Bifidobacterium longum
AR123009A1 (es) 2020-07-20 2022-10-19 Omya Int Ag Agente estabilizante para composición probiótica
WO2026017460A1 (en) 2024-07-19 2026-01-22 Saes Getters S.P.A. Stabilizing zeolites for probiotic composition

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634858A (pt) * 1962-07-19 1900-01-01
US3677898A (en) * 1969-01-31 1972-07-18 Ajinomoto Kk Acid protease and method of preparing the same
US3898132A (en) * 1972-08-24 1975-08-05 Int Feed Improvement Ass Inc Method of preparing stowable, dormant bacteria
US3957974A (en) * 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
FR2453215A1 (fr) * 1979-04-05 1980-10-31 Rhone Poulenc Ind Procede d'inclusion de micro-organismes dans une matrice de polymere
US4518696A (en) * 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
US4927763A (en) * 1984-03-21 1990-05-22 Chr. Hansen's Laboratory, Inc. Stabilization of dried bacteria extended in particulate carriers
US4592748A (en) * 1984-05-18 1986-06-03 Vortex Research Corp. Yoghurt based douche kit and assembly therefor
SE463598B (sv) * 1984-11-08 1990-12-17 Chemical Dynamics Sweden Ab Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
US5160745A (en) * 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
US4797289A (en) * 1987-03-09 1989-01-10 Reddy Malireddy S Enhancement of lactobacillus acidophilus growth and viability in yogurt and other cultured dairy products
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
GB8713601D0 (en) * 1987-06-10 1987-07-15 Unilever Plc Fermentation
US4859377A (en) * 1987-07-10 1989-08-22 The United States Of America, As Represented By The Secretary Of Agriculture Starch encapsulation of entomopathogens
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
SE465206B (sv) * 1989-12-22 1991-08-12 Eva Grahn Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
US5403799A (en) * 1992-12-21 1995-04-04 W. R. Grace & Co.-Conn. Process upset-resistant inorganic supports for bioremediation
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
US5486507A (en) * 1994-01-14 1996-01-23 Fuisz Technologies Ltd. Porous particle aggregate and method therefor
AUPM823094A0 (en) * 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
US5733774A (en) * 1995-02-02 1998-03-31 Ecoscience Corporation Method and composition for producing stable bacteria and bacterial formulations
US5733540A (en) * 1995-03-08 1998-03-31 Lee; Peter Poon-Hang Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
IT1276783B1 (it) * 1995-06-23 1997-11-03 Bracco Spa Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
US5785990A (en) * 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US5660790A (en) * 1996-08-13 1997-08-26 Litmus Concepts, Inc. PH and amine test elements
DK0924993T3 (da) * 1996-09-10 2002-01-28 Nestle Sa Afvandede fødevarer indeholdende mælkesyrebakterier
US5976579A (en) * 1997-07-03 1999-11-02 Mclean; Linsey Nutritional supplement for the prevention and treatment of excessive intestinal permeability
US6008027A (en) * 1997-07-17 1999-12-28 Langner; Bruce J. Enteric polymer coated capsule containing dried bacterial culture for supplying lactase
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
DE19819475A1 (de) * 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
JP2000060535A (ja) * 1998-08-21 2000-02-29 Kyowa Hakko Kogyo Co Ltd 微生物菌体の保存方法
CA2354054C (en) * 1998-12-11 2011-04-12 Urex Biotech, Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
US20010049115A1 (en) * 2000-01-17 2001-12-06 Collins John Kevin Vitro model for gastrointestinal inflammation
DE60127731T2 (de) * 2000-05-25 2007-08-16 Société des Produits Nestlé S.A. Probiotica zur Verwendung als Futter für Haustiere
IL156490A0 (en) * 2000-12-18 2004-01-04 Probiohealth Probiotic compounds derived from lactobacillus casei strain ke01
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
SI1565547T2 (sl) * 2002-06-28 2013-02-28 Biosearch S.A. Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
US7122370B2 (en) * 2003-01-14 2006-10-17 Randolph Stanley Porubcan Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life

Also Published As

Publication number Publication date
EP1680501A1 (en) 2006-07-19
IN2006DE02381A (pt) 2007-08-03
CA2545148A1 (en) 2005-05-26
EP1680501B1 (en) 2012-12-19
AU2004290037B2 (en) 2008-10-16
MXPA06005093A (es) 2006-12-11
US20050100559A1 (en) 2005-05-12
RU2006114581A (ru) 2007-12-20
MX294225B (en) 2012-01-04
CN1875094A (zh) 2006-12-06
RU2359027C2 (ru) 2009-06-20
WO2005047489A1 (en) 2005-05-26
AU2004290037A1 (en) 2005-05-26
JP2007508035A (ja) 2007-04-05
US20080145341A1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
ECSP045154A (es) Composiciones de fórmula para infantes que comrende cantidades aumentadas de alfa - lactalbumin
BRPI0412411A (pt) tetrahidro-1h-pirazol[3,4-c]piridinas substituìdas, composições que as contêm e utilização
ATE514345T1 (de) Zusammensetzung zur senkung des blutcholesterolspiegels
BR0210568A (pt) Conjugado, uso de um conjugado, composição farmacêutica, e, método para tratar câncer em um mamìfero
BR9900972A (pt) Uso de uma associação de lactobacilos para a preparação de uma composição para tratamento de vaginoses e vaginites, e composições farmacêuticas assim preparadas.
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
BRPI0415758A (pt) combinações de substáncias ativas fungicidas sinergìsticas
BRPI0409206A (pt) composições compreendendo cepas de lactobacillus plantarum em combinação com tanino e cepas de lactobacillus plantarum
FR2840903B1 (fr) Derive de glucose et de vitamine f, compositions le comprenant et utilisations pour ameliorer l'etat des poils et des cheveux
WO2005023185A3 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
BR0316776A (pt) Formula para anti-infeccioso tópico
BR0214706A (pt) Estrutura absorvente envolta
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
ATE286664T1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
TW200603746A (en) Iron sulfate based phosphate adsorbent
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
BR0213449A (pt) Comprimido mastigável contendo lisina
BR0211245A (pt) Alimento contendo proteìna compreendendo uma enzima de ligação cruzada e um hidrocolóide
BRPI0407176B8 (pt) composições compreendendo uma ou mais cepas de bifidobacterium e seus usos
BR0107701A (pt) Produtos alimentìcios e processos
DE59909607D1 (de) Tan-1057 derivate
MXPA04001779A (es) Modulacion de almacenamiento de vitamina.
PL367812A1 (en) Alpha-ketoglutarates of active ingredients and compositions containing same
DE502005010277D1 (de) Teinen

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 24, 8O C/C 11, 8O C/C 13, 10 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.